Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition-Reference-Cited by-同舟云学术

Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition

Published:2017-09-21 Issue:10 Volume:13 Page:1767-1781
ISSN:1554-8627
Container-title:Autophagy
language:en
Short-container-title:Autophagy

Author:

Kim Soo Hyun¹,Kim Gyuri¹²³,Han Dai Hoon⁴,Lee Milim¹,Kim Irene¹,Kim Bohkyung¹,Kim Kook Hwan⁵,Song Young-Mi⁶,Yoo Jeong Eun⁷,Wang Hye Jin⁸,Bae Soo Han⁵,Lee Yong-Ho¹³⁹^ORCID,Lee Byung-Wan¹³⁹^ORCID,Kang Eun Seok¹³⁹^ORCID,Cha Bong-Soo¹³⁹,Lee Myung-Shik¹⁵^ORCID

Affiliation:

1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

2. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

3. Graduate School, Yonsei University College of Medicine, Seoul, Korea

4. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea

5. Severance Biomedical Science Institute, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, Korea

6. Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto, Canada

7. Department of Pathology, Yonsei University College of Medicine, Seoul, Korea

8. Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea

9. Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15548627.2017.1356977

Reference47 articles.

1. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

2. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

3. Steatohepatitis: A tale of two “hits”?

4. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes

5. Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-apoptotic cell death in osteoarthritis: Recent advances and future;Biomedicine & Pharmacotherapy;2024-10

2. Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson’s disease model in rats: Role of AMPK/SIRT-1/PGC-1α signaling and autophagy;International Immunopharmacology;2024-09

3. Ezetimibe protects against Gentamycin-induced ototoxicity in rats by antioxidants, anti-inflammatory mechanisms, and BDNF upregulation;Immunopharmacology and Immunotoxicology;2024-08-13

4. Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches;Immunity & Ageing;2024-08-05

5. Mitigation of ROS-triggered endoplasmic reticulum stress by upregulating Nrf2 retards diabetic nephropathy;Biochemical and Biophysical Research Communications;2024-08